Your browser doesn't support javascript.
loading
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial.
Knop, Stefan; Mateos, Maria-Victoria; Dimopoulos, Meletios A; Suzuki, Kenshi; Jakubowiak, Andrzej; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Usenko, Ganna; Pour, Ludek; Cook, Mark; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna Marina; Campbell, Philip; Shelekhova, Tatiana; Yoon, Sung-Soo; Losava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Wang, Jianping; Wroblewski, Susan; Kudva, Anupa; Gries, Katharine S; Fastenau, John; San-Miguel, Jesus; Cavo, Michele.
Afiliação
  • Knop S; Department of Haematology and Oncology, Würzburg University Medical Center, Oberdürrbacher Straße 6, 97080, Würzburg, Germany. knop_s@ukw.de.
  • Mateos MV; University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
  • Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
  • Suzuki K; Japanese Red Cross Medical Center, Tokyo, Japan.
  • Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.
  • Doyen C; Université Catholique of Louvain, CHU UCL Namur, Yvoir, Belgium.
  • Lucio P; Champalimaud Centre for the Unknown, Lisbon, Portugal.
  • Nagy Z; Semmelweis University, Budapest, Hungary.
  • Usenko G; Dnipropetrovsk City Multidisciplinary Clinical Hospital No. 4, Dnipropetrovsk, Ukraine.
  • Pour L; University Hospital Brno, Brno, Czech Republic.
  • Cook M; University Hospitals Birmingham NHS Trust, Birmingham, UK.
  • Grosicki S; Silesian Medical University, Katowice, Poland.
  • Crepaldi A; Clinica de Tratamento E, Cuiaba, Brazil.
  • Liberati AM; Azienda Ospedaliera "Santa Maria", Terni, Italy.
  • Campbell P; Andrew Love Cancer Centre, Geelong, Australia.
  • Shelekhova T; Clinic of Professional Pathology, Saratov, Russia.
  • Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Losava G; LTD "Medinvent" Institute of Health, Tbilisi, Georgia.
  • Fujisaki T; Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Garg M; Leicester Royal Infirmary, Leicester, UK.
  • Wang J; Janssen Research and Development, Raritan, NJ, USA.
  • Wroblewski S; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Kudva A; Janssen Research and Development, Raritan, NJ, USA.
  • Gries KS; Janssen Research and Development, Raritan, NJ, USA.
  • Fastenau J; Janssen Research and Development, Raritan, NJ, USA.
  • San-Miguel J; Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain.
  • Cavo M; Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
BMC Cancer ; 21(1): 659, 2021 Jun 02.
Article em En | MEDLINE | ID: mdl-34078314
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Medidas de Resultados Relatados pelo Paciente / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Medidas de Resultados Relatados pelo Paciente / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article